PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 61 filers reported holding PEAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $229,639 | -78.4% | 900,548 | 0.0% | 0.01% | -76.7% |
Q4 2022 | $1,062,646 | -42.2% | 900,548 | 0.0% | 0.03% | -43.4% |
Q3 2022 | $1,837,000 | +32.5% | 900,548 | 0.0% | 0.05% | +23.3% |
Q2 2022 | $1,386,000 | -70.4% | 900,548 | -2.8% | 0.04% | -54.3% |
Q1 2022 | $4,677,000 | -18.5% | 926,232 | 0.0% | 0.09% | +113.6% |
Q4 2021 | $5,742,000 | – | 926,232 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roble, Belko & Company, Inc | 4,502 | $0 | 0.00% |